中证香港300内地高贝塔指数
Search documents
中证香港300内地高贝塔指数报1235.84点,前十大权重包含中国光大控股等
Jin Rong Jie· 2025-08-19 09:33
Core Insights - The China Securities Index Hong Kong 300 Mainland High Beta Index (H300CNHB) has shown significant growth, with a 15.44% increase over the past month, 36.85% over the past three months, and 46.81% year-to-date [1] Group 1: Index Performance - The index is currently reported at 1235.84 points [1] - The index is based on a starting point of 1000.0 points as of December 30, 2005 [1] Group 2: Index Holdings - The top ten weighted stocks in the index include: - Dongfang Zhenxuan (4.65%) - InnoCare Pharma (3.97%) - Sunac China (3.4%) - China Merchants Securities (3.09%) - China Cinda Asset Management (2.83%) - CICC (2.64%) - China Galaxy Securities (2.61%) - China Jinmao (2.51%) - CITIC Securities (2.41%) - China Everbright Holdings (2.37%) [1] Group 3: Sector Allocation - The index is fully composed of stocks listed on the Hong Kong Stock Exchange, with a 100% allocation [1] - Sector allocations within the index are as follows: - Financials: 27.97% - Information Technology: 18.42% - Healthcare: 17.55% - Real Estate: 15.64% - Consumer Discretionary: 11.74% - Communication Services: 5.49% - Industrials: 3.19% [1] Group 4: Index Adjustment Mechanism - The index samples are adjusted biannually, specifically on the next trading day after the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2]
中证香港300内地高贝塔指数报1121.21点,前十大权重包含中国金茂等
Jin Rong Jie· 2025-08-05 08:24
Group 1 - The core viewpoint of the article highlights the performance of the China Securities Hong Kong 300 Mainland High Beta Index, which has shown significant increases over various time frames, including a 14.17% rise in the past month, a 22.33% rise in the past three months, and a 33.19% rise year-to-date [1] - The index is designed to reflect the overall performance of securities listed on the Hong Kong Stock Exchange from multiple strategic investment perspectives, with a base date of December 30, 2005, set at 1000.0 points [1] - The top ten weighted stocks in the index include InnoCare Pharma (4.02%), Sunac China (3.78%), China Merchants Securities (2.93%), Dongfang Zhenxuan (2.79%), China Cinda Asset Management (2.69%), China Jinmao (2.6%), MicroPort Scientific (2.48%), CICC (2.42%), GF Securities (2.39%), and China Galaxy Securities (2.39%) [1] Group 2 - The index's holdings are entirely composed of stocks listed on the Hong Kong Stock Exchange, with a sector breakdown showing that finance accounts for 26.87%, information technology for 19.21%, healthcare for 17.51%, real estate for 16.45%, consumer discretionary for 10.51%, communication services for 6.08%, and industrials for 3.38% [1] - The index sample is adjusted biannually, with adjustments occurring on the next trading day following the second Friday of June and December each year [2] - In special circumstances, the index may undergo temporary adjustments, such as when a sample stock is delisted or undergoes corporate actions like mergers or suspensions [2]
中证香港300内地高贝塔指数报914.13点,前十大权重包含中国信达等
Jin Rong Jie· 2025-06-23 08:27
金融界6月23日消息,上证指数低开高走,中证香港300内地高贝塔指数 (H300CNHB,H30237)报914.13 点。 数据统计显示,中证香港300内地高贝塔指数近一个月上涨1.68%,近三个月下跌8.75%,年至今上涨 8.59%。 据了解,中证香港策略指数系列从多种策略投资的角度反映了在香港交易所上市证券的整体表现。该指 数以2005年12月30日为基日,以1000.0点为基点。 从指数持仓来看,中证香港300内地高贝塔指数十大权重分别为:融创中国(3.55%)、招商证券 (2.84%)、中国信达(2.64%)、中国金茂(2.44%)、中金公司(2.44%)、哔哩哔哩-W (2.43%)、越疆(2.38%)、英诺赛科(2.33%)、万科企业(2.3%)、新华保险(2.29%)。 从中证香港300内地高贝塔指数持仓的市场板块来看,香港证券交易所占比100.00%。 从中证香港300内地高贝塔指数持仓样本的行业来看,金融占比26.68%、房地产占比17.81%、信息技术 占比17.47%、医药卫生占比16.60%、可选消费占比11.38%、通信服务占比6.04%、工业占比4.02%。 资料显示,指数样本 ...
中证香港300内地高贝塔指数报890.07点,前十大权重包含华虹半导体等
Jin Rong Jie· 2025-06-03 08:07
Group 1 - The core viewpoint of the article highlights the performance of the CSI Hong Kong 300 Mainland High Beta Index, which reported a recent increase of 0.64% over the past month, a decrease of 6.38% over the last three months, and a year-to-date increase of 7.28% [1][2] - The CSI Hong Kong 300 Mainland High Beta Index is designed to reflect the overall performance of securities listed on the Hong Kong Stock Exchange from various strategic investment perspectives, with a base date of December 30, 2005, set at 1000.0 points [1][2] - The top ten holdings of the CSI Hong Kong 300 Mainland High Beta Index include MicroPort Scientific Corporation-B (4.17%), ZhongAn Online (3.32%), Hua Hong Semiconductor (2.82%), WuXi Biologics (2.75%), XPeng Inc. (2.73%), Guotai Junan Securities (2.59%), Ali Health (2.49%), JD Health (2.43%), MicroPort Medical (2.39%), and Country Garden Services (2.36%) [1][2] Group 2 - The industry composition of the CSI Hong Kong 300 Mainland High Beta Index shows that finance accounts for 23.18%, real estate for 21.15%, healthcare for 17.57%, consumer discretionary for 16.75%, information technology for 10.39%, communication services for 4.34%, materials for 2.82%, consumer staples for 1.91%, and industrials for 1.88% [2] - The index sample is adjusted biannually, with adjustments implemented on the next trading day following the second Friday of June and December each year. Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2]